Parkinsons Disease Home > Selegiline Hydrochloride (HCl) Information

People with Parkinson's disease may benefit from selegiline hydrochloride (HCl), a prescription drug sold under the brand name Eldepryl®. This medication is a monoamine oxidase inhibitor (MAOI). It is only approved for use in combination with carbidopa-levodopa medications such as Sinemet®, Sinemet® CR, or Parcopa®. Selegiline is specifically designed for people who are experiencing a reduced response to their carbidopa-levodopa therapy.
 
Most people tolerate this medication fairly well; however, it is not right for everyone. Prior to beginning treatment with selegiline hydrochloride, inform your healthcare provider about any other medications you are taking and any other medical conditions you have, especially liver or kidney disease.
 
(Click Selegiline for more information, including a detailed description of the medication's effects, dosing tips, and what to do if you miss a dose.)
 
Written by/reviewed by:
Last reviewed by: Arthur Schoenstadt, MD
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation
Advertisement


Topics & Medications

Quicklinks

Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.